These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
647 related articles for article (PubMed ID: 16026737)
1. Multiple myeloma: clinical features and indications for therapy. Dispenzieri A; Kyle RA Best Pract Res Clin Haematol; 2005; 18(4):553-68. PubMed ID: 16026737 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422 [TBL] [Abstract][Full Text] [Related]
3. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma. Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Sumna E; Martinek A; Horak P Neoplasma; 2003; 50(5):363-71. PubMed ID: 14628090 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic criteria of multiple myeloma. Kyle RA Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977 [TBL] [Abstract][Full Text] [Related]
5. Clinical aspects of multiple myeloma and related disorders including amyloidosis. Kyle RA Pathol Biol (Paris); 1999 Feb; 47(2):148-57. PubMed ID: 10192881 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management. Hillengass J; Moehler T; Hundemer M Recent Results Cancer Res; 2011; 183():113-31. PubMed ID: 21509683 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathies of undetermined significance. Kyle RA; Rajkumar SV Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Rajkumar SV; Lacy MQ; Kyle RA Blood Rev; 2007 Sep; 21(5):255-65. PubMed ID: 17367905 [TBL] [Abstract][Full Text] [Related]
9. [Benign monoclonal gammopathy]. Shirota T; Kondo M; Uchida H; Ito H Nihon Rinsho; 1995 Mar; 53(3):720-4. PubMed ID: 7699912 [TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma: recognition and management. George ED; Sadovsky R Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Kyle RA; Rajkumar SV Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088 [TBL] [Abstract][Full Text] [Related]
12. Advances in the diagnosis and management of myeloma. Greipp PR Semin Hematol; 1992 Jul; 29(3 Suppl 2):24-45. PubMed ID: 1509293 [No Abstract] [Full Text] [Related]
13. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Kyle RA; Rajkumar SV Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590 [TBL] [Abstract][Full Text] [Related]
15. Neurological aspects of multiple myeloma and related disorders. Dispenzieri A; Kyle RA Best Pract Res Clin Haematol; 2005; 18(4):673-88. PubMed ID: 16026744 [TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma: diagnosis and treatment. Nau KC; Lewis WD Am Fam Physician; 2008 Oct; 78(7):853-9. PubMed ID: 18841734 [TBL] [Abstract][Full Text] [Related]
17. [Monoclonal gammopathy of undetermined significance]. Chaïbi P; Merlin L; Thomas C; Piette F Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832 [TBL] [Abstract][Full Text] [Related]
18. [Monoclonal gammopathies of undetermined significance called "MGUS"]. Clément F Schweiz Med Wochenschr; 1989 Jul; 119(27-28):970-8. PubMed ID: 2508215 [TBL] [Abstract][Full Text] [Related]
19. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation. Rajkumar SV; Buadi F Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is important. Berenson JR; Yellin O Clin Lymphoma Myeloma; 2009 Aug; 9(4):311-5. PubMed ID: 19717382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]